NCT03878095 2025-11-17Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting24 enrolled
NCT04298008 2024-04-19AZD6738 Plus Durvalumab in Biliary Tract CancerSeoul National University HospitalPhase 2 Recruiting26 enrolled
NCT04298021 2024-04-19DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract CancerSeoul National University HospitalPhase 2 Active not recruiting74 enrolled